Art
J-GLOBAL ID:202002236114538839   Reference number:20A1933644

Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia

急性骨髄性白血病を治療する幹細胞ニッチからの白血病幹細胞放出【JST・京大機械翻訳】
Author (5):
Material:
Volume:Page: 607  Publication year: 2020 
JST Material Number: U7062A  ISSN: 2296-634X  Document type: Article
Article type: 文献レビュー  Country of issue: Switzerland (CHE)  Language: ENGLISH (EN)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
Acute myeloid leukemia (AML) i...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A1933644&from=J-GLOBAL&jstjournalNo=U7062A") }}
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
, 【Automatic Indexing@JST】
JST classification (2):
JST classification
Category name(code) classified by JST.
Blood cell tumors(=neoplasms)  ,  Chemistry,biochemistry and pathology of tumors(=neoplasms) 
Reference (150):
  • Abraham M., Pereg Y., Bulvik B., Klein S., Mishalian I., Wald H., et al (2017). Single dose of the CXCR4 antagonist BL-8040 induces rapid mobilization for the collection of human CD34(+) cells in healthy volunteers. Clin. Cancer Res. 23 6790-6801. doi: 10.1158/1078-0432.CCR-16-2919
  • Advani A. S., Cooper B., Visconte V., Elson P., Chan R., Carew J., et al (2019). A phase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in combination with Ixazomib for relapsed refractory acute myeloid leukemia. Clin. Cancer Res. 25 4231-4237. doi: 10.1158/1078-0432.CCR-18-3886
  • Andreeff M., Borthakur G., Zeng Z. H., Kelly M. A., Wang R. Y., McQueen T. J., et al (2014). Mobilization and elimination of FLT3-ITD+ acute myelogenous leukemia (AML) stem/progenitor cells by plerixafor, G-CSF, and sorafenib: phase I trial results in relapsed/refractory AML patients. J. Clin. Oncol. 32:33. doi: 10.1200/jco.2014.32.15_suppl.7033
  • Arcangeli M. L., Bardin F., Frontera V., Bidaut G., Obrados E., Adams R. H., et al (2014). Function of Jam-B/Jam-C interaction in homing and mobilization of human and mouse hematopoietic stem and progenitor cells. Stem Cells 32 1043-1054. doi: 10.1002/stem.1624
  • Arranz L., Urbano-Ispizua A., Mendez-Ferrer S. (2013). Mitochondria underlie different metabolism of hematopoietic stem and progenitor cells. Haematologica 98 993-995. doi: 10.3324/haematol.2013.084293
more...
Terms in the title (5):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page